The European Research Council (ERC) awarded Dr Alexander Titz, who is the head of the "Chemical Biology of Carbohydrates" junior research group of the Helmholtz Centre for Infection Research (HZI) and
The German Center for Infection Research (DZIF) is one of nine founding organisations that have launched the alliance “CARA” (Conscience of Antimicrobial Resistance Accountability). Today, a
In chronic hepatitis B patients, a discontinuation of treatment can lead to cure: as scientists from the Hannover Medical School (MHH) have discovered. DZIF researcher Prof Markus Cornberg and his
Over a period of five years, an international team of scientists has documented in detail the treatment success of patients with severe tuberculosis. During this period, the team also reviewed the
The Heidelberg virologist Prof Ralf Bartenschlager will receive the Lasker Award in New York for his research on the hepatitis C virus. The prize, worth 250,000 US dollars, is considered the
The DZIF Academy is pleased to open the call for application for the third DZIF Prize for Translational Infection Research. The German Center for Infection Research (DZIF) will award a prize of 5.000
DZIF scientists at the Heidelberg University Hospital developed a virus blocker against hepatitis B and D, which has been successful in two clinical trials
There are four globally endemic human coronaviruses which, together with the better known rhinoviruses, are responsible for causing common colds. Usually, infections with these viruses are harmless to
According to National Reference Center for Surveillance of Nosocomial Infections estimates, up to 15,000 patients die of hospital-acquired infections in Germany every year. Here, multidrug-resistant
DZIF researchers have discovered that a protein which is well known for its role as a tumor suppressor is also required for inhibition of the replication of the coronavirus that causes SARS. The
